SCIESCOPUSQ3
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
OXFORD UNIV PRESS, United Kingdom
JAPANESE JOURNAL OF CLINICAL ONCOLOGY is an academic journal published by OXFORD UNIV PRESS (United Kingdom). Identifiers: ISSN 0368-2811, eISSN 1465-3621. Indexed in SCIE, SCOPUS. Metrics: JIF 2.2, CiteScore 3.8, SJR 0.613, SNIP 0.79. Subject areas: ONCOLOGY. tlooto lists 6,722 papers from this journal.
CiteScore
3.80
Scopus citation metric
SJR
0.613
SCImago rank
SNIP
0.79
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 0368-2811
- eISSN
- 1465-3621
- Abbreviation
- JPN J CLIN ONCOL
- Publisher
- OXFORD UNIV PRESS
- Country
- United Kingdom
Web of Science categories
SCIEONCOLOGY
Scopus ASJC categories
1306 Cancer Research2730 Oncology2741 Radiology
Keywords
Oncology
Papers in this journal
Recent papers
- Trends in net survival for cancers of the liver and pancreas in Japan, 2000-14 (CONCORD-3).
2026
- Age-standardized mortality-to-incidence ratio for thyroid cancer in the world.
2026
- Age-standardized mortality-to-incidence ratio for bladder cancer in the world.
2026
- A randomized controlled trial of metastasis-directed therapy for oligometastases in breast cancer: OLIGAMI trial (JCOG2110).
2026
- International trends in cancer mortality revisited: Japan’s site-specific progress and remaining challenges until 2024
2026 · 1 citations
Most cited papers
- European Organization for Research and Treatment of Cancer.
2000 · 670 citations
- Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project.
2015 · 555 citations
- Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project.
2012 · 512 citations
- A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).
2010 · 507 citations
- Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05).
2019 · 402 citations